Immunovant Corp (IMVT) Operating Sales Margin

Corporate company logo of Immunovant Therapeutics (IMVT)

The success of Immunovant, Inc. (IMVT) is based on the clinical progress of its anti-FcRn antibody and strict cost control. The EBIT margin visualizes this trend, where 0.00 reflects the baseline level of the metric. An innovative approach to treating autoimmune pathologies creates the foundation for future sales. The powerful research potential of monoclonal antibodies supports the company's financial health during the current stages of trials.

Immunovant (IMVT): Return on Sales by Operating Profit from 07/04/2022 to 11/19/2026

Comprehensive metric breakdowns and analytics for Immunovant, Inc. (IMVT)

Basic company analysis:IMVT, Immunovant, Inc.
Brand item of Immunovant Therapeutics

Immunovant, Inc. (IMVT) requires colossal operating expenditures to develop innovative methods for reducing pathogenic antibodies to treat severe autoimmune diseases. Analyzing the history of operating margin changes allows for an assessment of the share of earnings before interest and taxes (EBIT) in revenue, which is critical for determining cost management efficiency and evaluating the sustainability of the company's business model prior to entering the commercialization stage.

Competing companies

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|Operating Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Operating Profitability|Profitability of Operations Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Operating Sales Margin|Aurinia Pharmaceuticals Inc. (AUPH) - Operating Margin|Operating Sales Margin BCRX|Operating Return on Sales Vera Therapeutics Inc VERA|Operating Sales Margin DNTH (Dianthus Pharma)|Profitability of Operations Pharvaris N.V.|AbCellera Biologics Inc - Operating Sales Margin|Tourmaline Bio (TRML) - Operating Return on Sales|PGEN - Operating Profitability|Operating Profit Rate PHAR (Pharming Group NV)|NKTR: Operating Margin|Upstream Bio Corp - Operating Profit Rate|Operating Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Profitability of Operations|Operating Margin GOSS|Operating Sales Margin KalVista Pharmaceuticals, Inc. KALV|Operating Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Operating Return on Sales|SVRA - Operating Profitability|Rigel Pharmaceuticals - Operating Profit Ratio|AnaptysBio Corp (ANAB) - Operating Profitability|ATXS - Profitability of Operations|Operating Profitability enGene Holdings Inc.|RAPT: Operating Profit Rate|Operating Margin JBIO|Operating Sales Margin aclaristx.com ACRS|Operating Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Operating Return on Sales|Cabaletta Bio, Inc - Operating Margin|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com